Interventional Cardiology Devices Market by type (Angioplasty, Catheters, Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath)) - Global Forecast to 2022
The interventional cardiology devices market is expected to reach USD 20.85 Billion by 2022 from USD 13.50 Billion in 2016 at a CAGR of 7.5%. The base year for this study is 2016 and the forecast period is 2017–2022.
The key players in the interventional cardiology devices market include Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo (Japan), Cordis (US), B. Braun (Germany), C.R. Bard (US), Biosensors (Singapore), and BIOTRONIK (Germany).
Target Audience for this Report:
- Manufacturers and vendors of interventional cardiology devices
- Research associations related to non-communicable diseases
- Various research and consulting firms
- Distributors of interventional cardiology devices
- Contract research manufacturers of interventional cardiology devices
- Healthcare institutions
- Research institutes
The global interventional cardiology devices market is segmented based on type and region.
The global interventional cardiology devices market is dominated by North America, followed by Europe. North America will continue to dominate the global market in the forecast period.
However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered on Japan, China, and India. Factors such as the rising focus of major players in emerging Asia Pacific countries and government support are driving the growth of the interventional cardiology devices market in this region.
List of Figures (40 Figures)
Figure 1 Research Design
Figure 2 Bottom-Up Approach
Figure 3 Top-Down Approach
Figure 4 Data Triangulation Methodology
Figure 5 Angioplasty Balloons Market, By Type, 2017 vs 2022 (USD Billion)
Figure 6 Angioplasty Stents Market, By Type, 2017 vs 2022 (USD Billion)
Figure 7 Catheters Market, By Type, 2017 vs 2022 (USD Billion)
Figure 8 Plaque Modification Devices Market, By Type, 2017 vs 2022 (USD Billion)
Figure 9 Hemodynamic Flow Alteration Devices Market, By Type, 2017 vs 2022 (USD Billion)
Factors such as the high degree of consolidation, the high cost of devices, and complex regulatory framework for the approval of new products may restrain the market’s growth to a certain extent.
Category: Market Research Publishers and RetailersCompany about: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...